...
首页> 外文期刊>Zeitschrift fur Gastroenterologie >Diffuse malignant peritoneal mesothelioma (DMPM) a rare diagnosis
【24h】

Diffuse malignant peritoneal mesothelioma (DMPM) a rare diagnosis

机译:弥漫性恶性腹膜间皮瘤(DMPM)罕见诊断

获取原文
获取原文并翻译 | 示例
           

摘要

Diffuse malignant peritoneal mesothelioma (DMPM) is a rare diagnosis, found more frequently in men than in women. Symptoms are unspecific abdominal disorders making that diagnosis difficult to set. Causes of DMPM are yet to be discovered in entirety. Asbestos exposure is the reason for approximately 7 % of all peritoneal mesotheliomas. Until the evaluation of systematic cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) DMPM was a fatal diagnosis with a median overall survival (OS) of 4-13 months. The prognosis of DMPM dramatically improved with implementation of CRS and HIPEC to an OS of 30-92 month nowadys. CRS and HIPEC were performed in this case.
机译:弥漫性恶性腹膜间皮瘤(DMPM)是一种罕见的诊断,男性更常见于男性。 症状是未指定的腹部疾病,使诊断难以设置。 尚未发现DMPM的原因。 石棉暴露是约7%的腹膜间皮瘤的原因。 直到评估系统性细胞功能性手术(CRS)和高温腹膜内化疗(HIPEC)DMPM是致命诊断,中位数生存(OS)为4-13个月。 DMPM的预后显着改善了CRS和HIPEC的实施到30-92个月NOWAYYS。 在这种情况下进行CRS和HIPEC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号